Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tajhal Dayaram

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Journal of Cellular Physiology|March 28, 2008
Effect of transforming viruses on molecular mechanisms associated with cancerTajhal Dayaram, Susan J Marriott
Virology|May 17, 2011
The HTLV-1 Tax oncoprotein represses Ku80 gene expressionRazvan I Ducu, Tajhal Dayaram, Susan J Marriott
Journal of Virology|September 28, 2007
Activation of the human T-cell leukemia virus type 1 long terminal repeat by the ternary complex factor Elk-1Heather Y Winter, Tajhal Dayaram, Susan J Marriott
Retrovirology|December 18, 2007
Ubiquitination of HTLV-I Tax in response to DNA damage regulates nuclear complex formation and nuclear exportMichael L Gatza, Tajhal Dayaram, Susan J Marriott
Plos One|February 14, 2013
Activation of WIP1 phosphatase by HTLV-1 Tax mitigates the cellular response to DNA damageTajhal Dayaram, Francene J Lemoine, Lawrence A Donehower, et al.
Cell Cycle (Georgetown, Tex.)|January 22, 2020
WIP1 dephosphorylation of p27<sup>Kip1</sup> Serine 140 destabilizes p27<sup>Kip1</sup> and reverses anti-proliferative effects of ATM phosphorylationByung-Kwon Choi, Kenichiro Fujiwara, Tajhal Dayaram, et al.
Nature Immunology|June 6, 2006
C/EBPbeta is required for 'emergency' granulopoiesisHideyo Hirai, Pu Zhang, Tajhal Dayaram, et al.
The Journal of Pathology|December 31, 2013
Effects of TP53 mutational status on gene expression patterns across 10 human cancer typesNeha Parikh, Susan Hilsenbeck, Chad J Creighton, et al.
Plos One|February 7, 2015
WIP1 phosphatase as a potential therapeutic target in neuroblastomaMark Richter, Tajhal Dayaram, Aidan G Gilmartin, et al.
Cancer Research|June 19, 2004
A transcriptional profiling study of CCAAT/enhancer binding protein targets identifies hepatocyte nuclear factor 3 beta as a novel tumor suppressor in lung cancerBalazs Halmos, Daniela S Bassères, Stefano Monti, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Journal of Cellular Physiology|March 28, 2008
Effect of transforming viruses on molecular mechanisms associated with cancerTajhal Dayaram, Susan J Marriott
Virology|May 17, 2011
The HTLV-1 Tax oncoprotein represses Ku80 gene expressionRazvan I Ducu, Tajhal Dayaram, Susan J Marriott
Journal of Virology|September 28, 2007
Activation of the human T-cell leukemia virus type 1 long terminal repeat by the ternary complex factor Elk-1Heather Y Winter, Tajhal Dayaram, Susan J Marriott
Retrovirology|December 18, 2007
Ubiquitination of HTLV-I Tax in response to DNA damage regulates nuclear complex formation and nuclear exportMichael L Gatza, Tajhal Dayaram, Susan J Marriott
Plos One|February 14, 2013
Activation of WIP1 phosphatase by HTLV-1 Tax mitigates the cellular response to DNA damageTajhal Dayaram, Francene J Lemoine, Lawrence A Donehower, et al.
Cell Cycle (Georgetown, Tex.)|January 22, 2020
WIP1 dephosphorylation of p27<sup>Kip1</sup> Serine 140 destabilizes p27<sup>Kip1</sup> and reverses anti-proliferative effects of ATM phosphorylationByung-Kwon Choi, Kenichiro Fujiwara, Tajhal Dayaram, et al.
Nature Immunology|June 6, 2006
C/EBPbeta is required for 'emergency' granulopoiesisHideyo Hirai, Pu Zhang, Tajhal Dayaram, et al.
The Journal of Pathology|December 31, 2013
Effects of TP53 mutational status on gene expression patterns across 10 human cancer typesNeha Parikh, Susan Hilsenbeck, Chad J Creighton, et al.
Plos One|February 7, 2015
WIP1 phosphatase as a potential therapeutic target in neuroblastomaMark Richter, Tajhal Dayaram, Aidan G Gilmartin, et al.
Cancer Research|June 19, 2004
A transcriptional profiling study of CCAAT/enhancer binding protein targets identifies hepatocyte nuclear factor 3 beta as a novel tumor suppressor in lung cancerBalazs Halmos, Daniela S Bassères, Stefano Monti, et al.
Pageof 3